Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis

OBJECTIVES: Mortality and worsening of organ function are desirable endpoints for clinical trials in systemic sclerosis (SSc). The aim of this study was to identify factors that allow enrichment of patients with these endpoints, in a population of patients from the European Scleroderma Trials and Re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Rheum Dis
Main Authors: Becker, Mike, Graf, Nicole, Sauter, Rafael, Allanore, Yannick, Curram, John, Denton, Christopher P, Khanna, Dinesh, Matucci-Cerinic, Marco, de Oliveira Pena, Janethe, Pope, Janet E, Distler, Oliver
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2019
Assuntos:
Systemic Sclerosis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6788922/
https://ncbi.nlm.nih.gov/pubmed/31227488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2019-215145
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados